OASIS | Jotup

Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific Meeting

Retrieved on:

월요일, 10월 16, 2023

ALPHARETTA, Ga., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that key data from the Phase 1/2a OASIS clinical trial were presented at The Retina Society 56th Annual Scientific Meeting. The results of the trial demonstrate the key benefits of Clearside’s patented suprachoroidal delivery platform and its lead drug candidate, CLS-AX (axitinib injectable suspension) being developed for the treatment of neovascular age-related macular degeneration (wet AMD or nAMD).

Key Points:

ALPHARETTA, Ga., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that key data from the Phase 1/2a OASIS clinical trial were presented at The Retina Society 56th Annual Scientific Meeting.
Based on the data from OASIS, CLS-AX is currently being investigated in a Phase 2b clinical trial entitled ODYSSEY.
“Our trial is enrolling as planned and we expect data from ODYSSEY in the third quarter of 2024.
In the OASIS and Extension Study, participants with wet AMD who were sub-responders with active disease at screening were followed for up to 6 months after CLS-AX treatment.

Home health and hospice professionals can save 25% on new Board of Medical Specialty Coding & Compliance (BMSC) certifications in October.

Retrieved on:

화요일, 10월 3, 2023

CMS, Centers for Medicare & Medicaid Services, Therapy, Record, Medicare, Medical specialty, AHCC, Gold, Person-centered therapy, Home care, Knowledge, Pharmacology, Nursing, Diagnosis

BRENTWOOD, Tenn., Oct. 3, 2023 /PRNewswire-PRWeb/ -- For the month of October, home health and hospice professionals can save 25% on new Board of Medical Specialty Coding & Compliance (BMSC) certifications. BMSC is the credentialing arm of the Association of Home Care Coding & Compliance (AHCC), the leading home health professional community of DecisionHealth. BMSC credentials represent the gold standard of knowledge in home care and hospice and are used to identify leaders in coding and OASIS accuracy.

Key Points:

BMSC offers three home health professional credentials: Home Care Coding Specialist - Diagnosis (HCS-D), Home Care Coding Specialist - Hospice (HCS-H), and Home Care Clinical Specialist - OASIS (HCS-O).
BRENTWOOD, Tenn., Oct. 3, 2023 /PRNewswire-PRWeb/ -- For the month of October, home health and hospice professionals can save 25% on new Board of Medical Specialty Coding & Compliance (BMSC) certifications.
BMSC is the credentialing arm of the Association of Home Care Coding & Compliance (AHCC), the leading home health professional community of DecisionHealth.
Home Care Coding Specialist - Hospice (HCS-H) , earned by professionals skilled in classifying medical data from hospice patient records.

Give the Ultimate Gift this Holiday Season: An Unforgettable Winter Getaway at Four Seasons Resort Orlando at Walt Disney World Resort

Retrieved on:

월요일, 9월 18, 2023

ORLANDO, Fla., Sept. 18, 2023 /PRNewswire/ -- This festive season, escape to Four Seasons Resort Orlando at Walt Disney World Resort, a AAA Five Diamond Resort where the most wonderful time of the year includes palm trees twinkling in glittering lights, heated infinity-edge pools and a lazy river, and elevated resort offerings such as rooftop Michelin-starred dining complete with dazzling fireworks views. Plus, a special connectivity to Walt Disney World Resort enables guests to experience magical holiday events at the Disney Theme Parks, such as "Mickey's Very Merry Christmas Party" at Magic Kingdom Park, and the brand-new nighttime celebration "Disney Jollywood Nights" at Disney's Hollywood Studios.

Key Points:

A spectacular season of holiday joy awaits at Walt Disney World Resort with enchanting events offered at all four Disney Theme Parks and beyond, beginning November 9, 2023.
Guests of Four Seasons who wish to explore the excitement of the Walt Disney World Resort Theme Parks can enjoy access to the resort's lobby level Disney Planning Center.
Additionally, the resort offers complimentary transportation in a luxury motor coach to the four main Disney Theme Parks.
For more information on reserving a winter getaway or to plan ahead for a springtime escape, visit the web site or call 1-800-267-3046.

Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress

Retrieved on:

월요일, 9월 11, 2023

DUBLIN, Sept. 11, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual Psych Congress (Psych Congress), which took place Sept. 6-10, 2023 in Nashville. This research reflects the company's continued commitment to improving care for, and understanding the unique needs of, people living with serious chronic diseases.

Key Points:

— Poster Presentations Highlight Company's Broad Research Commitment to Serious Mental Illness, Addiction and Narcolepsy —
DUBLIN, Sept. 11, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual Psych Congress (Psych Congress), which took place Sept. 6-10, 2023 in Nashville.
This research reflects the company's continued commitment to improving care for, and understanding the unique needs of, people living with serious chronic diseases.
"Psych Congress offers an important opportunity for scientific exchange and information sharing as we seek to advance care for people living with serious, complex diseases.
This year's presentations further reinforce Alkermes' leadership and experience in the field of neuroscience," said Craig Hopkinson, M.D., Chief Medical Officer and Executive Vice President of Research & Development at Alkermes.

Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress

Retrieved on:

월요일, 9월 11, 2023

DUBLIN, Sept. 11, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual Psych Congress (Psych Congress), which took place Sept. 6-10, 2023 in Nashville. This research reflects the company's continued commitment to improving care for, and understanding the unique needs of, people living with serious chronic diseases.

Key Points:

— Poster Presentations Highlight Company's Broad Research Commitment to Serious Mental Illness, Addiction and Narcolepsy —
DUBLIN, Sept. 11, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual Psych Congress (Psych Congress), which took place Sept. 6-10, 2023 in Nashville.
This research reflects the company's continued commitment to improving care for, and understanding the unique needs of, people living with serious chronic diseases.
"Psych Congress offers an important opportunity for scientific exchange and information sharing as we seek to advance care for people living with serious, complex diseases.
This year's presentations further reinforce Alkermes' leadership and experience in the field of neuroscience," said Craig Hopkinson, M.D., Chief Medical Officer and Executive Vice President of Research & Development at Alkermes.

DecisionHealth announces a special Coding, OASIS & Documentation QA Virtual Boot Camp, October 17-18, 2023

Retrieved on:

월요일, 8월 28, 2023

Accountability Act, Travel, Multimedia, Coding, Medicare, Health Insurance Portability and Accountability Act, Documentation, Publication, Customer service, Patient, QA, Diagnosis, News, HIPAA, Medical device, Hospital, Nursing

BRENTWOOD, Tenn, Aug. 28, 2023 /PRNewswire-PRWeb/ -- Accurate coding has become an essential component of defending a medical record, and the role of the seasoned Home Care Coding Specialist—Diagnosis (HCS-D) certified coder has expanded to include OASIS review as an emerging job function. To address the need for training and continuing education around these topics, DecisionHealth is excited to announce a special Coding, OASIS & Documentation QA Virtual Boot Camp, October 17–18, 2023.

Key Points:

To address the need for medical coder training around OASIS, diagnosis coding, and compliant documentation, DecisionHealth is excited to announce a special Coding, OASIS & Documentation QA Virtual Boot Camp, October 17–18, 2023.
To address the need for training and continuing education around these topics, DecisionHealth is excited to announce a special Coding, OASIS & Documentation QA Virtual Boot Camp, October 17–18, 2023.
"This unique training opportunity was recorded during the 2023 Home Health Coding Summit and has been formatted into a virtual event for home health coders who were unable to travel and/or are looking to become more efficient in OASIS, coding, and documentation QA."
This essential review includes more than simply knowing how to select accurate diagnosis codes and correct OASIS responses.

Oasis Amenities Grows as It Focuses on Building Oasis Springs Aquatic Facilities for Real Estate Developers

Retrieved on:

수요일, 8월 23, 2023

Now, Oasis Amenities is focusing its growth on creating more of these large aquatic amenities, while it also offers planning, design and construction services for community facilities like clubhouses, sports courts and entrance features.

Key Points:

Now, Oasis Amenities is focusing its growth on creating more of these large aquatic amenities, while it also offers planning, design and construction services for community facilities like clubhouses, sports courts and entrance features.
“We will soon be announcing several major new aquatic amenities for master-plan developments in the Florida, Texas, and Oklahoma regions,” said Christopher Souza, President and CEO of Oasis Amenities.
“We are finding tremendous interest from real estate owners and developers for our approach – a one-stop shop for creating a world-class aquatic amenity.
Prior to joining Oasis Amenities, Souza held senior leadership roles at Tavistock Development Company and Crystal Lagoons.

BlueWind Medical's Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

Retrieved on:

목요일, 8월 17, 2023

PARK CITY, Utah, Aug. 17, 2023 /PRNewswire/ -- BlueWind Medical, Ltd. today announced that the US Food and Drug Administration (FDA) granted a De Novo marketing request for the Revi System, a transformative tibial neuromodulation therapy for the treatment of the symptoms of urgency incontinence alone or in combination with urinary urgency. Physicians should follow clinical guidelines as applicable and should use their discretion to determine if Revi can be used before patients fail or not tolerate more conservative therapy. The De Novo grant is for men and women with urge urinary incontinence (UUI) and was based on results from the OASIS pivotal trial, in which Revi demonstrated statistically significant improvement in the reduction of symptoms of UUI compared to baseline and a favorable safety profile.

Key Points:

The Revi Implant is a small, battery-free device that is implanted near the ankle during a single, minimally invasive outpatient procedure performed under local anesthesia.
When activated the Revi implant stimulates the posterior tibial nerve to provide relief from UUI.
At 12 months, 82.0% (114/139) of subjects completing the study achieved at least a 50% reduction in urge incontinence episodes.
Moreover, the patient-centric nature of Revi facilitates individually tailored treatment which resulted in an increased response rate over time.

ISS and Glass Lewis Back Oasis’s Director Nominee in Recognition of Kusuri No Aoki’s Weak Governance and Underperformance and Oasis Addresses Aoki’s Misleading Counter-Arguments

Retrieved on:

목요일, 8월 10, 2023

In its recent report, ISS concluded that the “poor corporate governance system” raises concerns regarding “undue influence of the founding family over the board and the company”.

Key Points:

In its recent report, ISS concluded that the “poor corporate governance system” raises concerns regarding “undue influence of the founding family over the board and the company”.
ISS thus recommended that shareholders support the Oasis-proposed independent Outside Director nominee Mr. Yoshiaki Ikei and important parts of Oasis’s proposed governance reforms.
In fact, Oasis has been seeking dialogue with the Company about many of the questions raised in our presentation.
The Document is not intended to solicit or seek shareholders' agreements to jointly exercise any voting rights with Oasis.

The Double Digit Growth of the EDA (Electronic Design Automation) Market and How Magic2 Plans to Revolutionize the Process

Retrieved on:

월요일, 7월 31, 2023

From the News: Magic2, is an AI driven electronic design automation (EDA) software Suite helping engineers to speed up time consuming task work during the integrated circuits (IC) design phase.

Key Points:

From the News: Magic2, is an AI driven electronic design automation (EDA) software Suite helping engineers to speed up time consuming task work during the integrated circuits (IC) design phase.
Magic2 consists of eight integrated software applications that each cover specific component processes of the IC design cycle.
The tools complement each other and will help drastically reduce the development costs and speed up the IC design development cycle.
So the race is on for creating IP in the EDA market and with a little " magic " it will keep growing.